Modeling the Genetics of Uveal Melanoma - Summary - MDSpire
Feature

Modeling the Genetics of Uveal Melanoma

Researchers have developed a genetically engineered mouse model that mirrors the genetic evolution of uveal melanoma

  • April 21, 2026

  • 3 min

Share

Uveal melanoma (UM) is the most prevalent primary intraocular cancer in adults, often leading to metastases, primarily in the liver, which result in poor survival rates. Lack of effective experimental models has hindered research. A new genetically engineered mouse model mimics the genetic changes seen in human UM and preserves the immune system, enabling the study of immunotherapies. The model reveals stepwise progression in tumor development and highlights the tumor cell transitions, offering valuable insights for potential treatments.

Original Source(s)

Modeling the Genetics of Uveal Melanoma

  • April 21, 2026

Related Content

This Week’s Biopharma News: KRAS Breakthrough and ADC Momentum

Revolution’s KRAS breakthrough, strong ADC signals from GSK, and shifting regulatory and dealmaking dynamics define this week in biopharma

  • April 21, 2026

  • 4 min
This Week’s CGT News: New FDA Genome Editing Guidance 

Our latest roundup highlights tighter FDA expectations for genome editing safety, advances in CRISPR precision and delivery, and continued momentum for off-the-shelf CAR-T

  • April 20, 2026

  • 6 min
‘Prostate Screening Saved My Life’—Is That Really True in Most Cases?

Prostate specific antigen (PSA) screening remains one of the most controversial of “standard” medical practices. As recently as the 2026 Super Bowl, one of the more unusual TV advertisements, sponsore...